FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ampicillin for Injection, USP
Status: Discontinuation
»Therapeutic Categories: Antiviral

Hospira, Inc. (New 12/14/2020)

Company Contact Information:

Presentation Posting Date Related Information
250 mg/vial; Single Dose Vial (powder) (NDC 00409-3719-01) 12/14/2020 Discontinuation of the manufacture of the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English